DeviceTalks Minnesota 2026 Show Preview: Speakers, Exhibitors and More

Why It Matters

The conference links device innovators with manufacturing and digital‑health partners, accelerating time‑to‑market while mitigating supply‑chain risk. Its speaker and exhibitor lineup highlights the accelerating convergence of hardware and software in med‑tech.

Key Takeaways

• DeviceTalks Minnesota returns May 4, 2026 at University of Minnesota
• Keynotes feature Abbott, Solventum, HistoSonics, and Medical 21 leaders
• Cretex Medical highlights vertical integration and advanced additive manufacturing
• S3 Connected Health provides digital‑health strategy, SaMD, and cybersecurity services
• Tecan offers high‑mix, high‑complexity contract manufacturing with global reach

Pulse Analysis

DeviceTalks has become a cornerstone event for the U.S. medical‑device ecosystem, drawing engineers, executives and investors to the University of Minnesota each spring. The 2026 edition, slated for May 4, continues the tradition of pairing high‑profile keynotes with deep‑dive panels that explore regulatory shifts, emerging technologies and market dynamics. By situating the conference in the Twin Cities—a hub for biotech talent and supply‑chain infrastructure—organizers ensure attendees gain both strategic insight and practical networking opportunities.

A notable theme this year is the tightening bond between hardware manufacturing and digital health. Exhibitors like Cretex Medical and Tecan showcase vertically integrated, high‑mix contract manufacturing that reduces lead times and supply‑chain exposure, while S3 Connected Health demonstrates how software‑as‑a‑medical‑device (SaMD) platforms and cybersecurity frameworks can be woven into device lifecycles from day one. These capabilities reflect broader industry pressures to accelerate product launches, meet stringent FDA expectations and deliver connected patient experiences.

For med‑tech companies, the event offers more than product showcases; it serves as a marketplace for partnership formation and risk mitigation. Engaging with contract manufacturers can unlock access to additive‑manufacturing and precision assembly without capital‑intensive investments, while digital‑health collaborators help translate data streams into reimbursable services. As the sector pivots toward integrated, patient‑centric solutions, DeviceTalks Minnesota provides a critical forum to align technology roadmaps with commercial realities, positioning participants to capture growth in a rapidly evolving market.